Warning letter
The Sanapac Co., Inc.: warning letter of Dec 10, 2004
FDA warning letter UCM146705 · Philadelphia District Office
Key facts
| Reference number | UCM146705 |
|---|---|
| Company | The Sanapac Co., Inc. |
| Subject | Dietary Supplement/Promotional Claims False & Misleading/Adulterated/Misbranded |
| Issue date | Dec 10, 2004 |
| Posted date | Dec 10, 2004 |
| Issuing office | Philadelphia District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 101.36(e)(6), 101.36(e), 190.6, 101.93, 101.4(h), 101.36(b)(2), 101.36(b)(2)(i), 101.36(b)(3) |
| Country | 3 |
| Inspection city | Dallas |
| Inspection ZIP | 18612-6131 |
| Inspection start date | Oct 7, 2004 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: